Global Underactive Bladder Market Size & Share Report, 2024-2032
Underactive Bladder Market Size, Forecast Trends Report, 2024-2032

Underactive Bladder Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Pharmacotherapy, Surgical Methods, Urethral Assist Device, Stem Cell and Gene Therapies); By Route of Administration; By End User; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

  • Published Date:Feb-2024
  • Pages: 115
  • Format: PDF
  • Report ID: PM4255
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

The global underactive bladder market size and share was valued at USD 458.99 million in 2023 and is expected to grow at a CAGR of 5.3% during the forecast period.

An underactive bladder is a condition where the bladder experiences reduced strength and duration of contraction, resulting in prolonged bladder emptying or inability to empty the bladder within a normal period.

The global underactive bladder market is anticipated to grow significantly in the coming years due to several factors, such as the increasing geriatric population. As people age, the muscles in the bladder become weaker, leading to a decrease in bladder function and an increase in the likelihood of underactive bladders. With the number of people aged 65 and older projected to reach nearly 2 Million by 2050, the demand for effective treatments and products that can help manage this condition is expected to rise. Advances in medical technology have also played a crucial role in the growth of the underactive bladder market. New medications, surgical procedures, and non-invasive devices have been developed to improve bladder function and alleviate symptoms associated with underactive bladders. These technological advancements have made it easier for patients to access effective treatments, further fueling market growth.

Underactive Bladder Market Size

To Understand More About this Research: Request a Free Sample Report

However, the market is hindered by the high cost of some treatments. Advanced treatments like sacral neuromodulation therapy or urethral bulking agents could be expensive, making them inaccessible to some patients. In addition, the cost of these treatments discourages some patients from seeking treatment altogether.

The underactive bladder market report details key market dynamics to help industry players align their business strategies with current and future trends. It examines technological advances and breakthroughs in the industry and their impact on the market presence. Furthermore, a detailed regional analysis of the industry at the local, national, and global levels has been provided. 

Growth Drivers

Increasing prevalence of urinary incontinence

Urinary incontinence, which affects millions of people worldwide, is the loss of bladder control, resulting in involuntary leakage of urine. This condition can be caused by various factors such as age, obesity, childbirth, and neurological disorders. As the global population ages, the prevalence of urinary incontinence is expected to increase, leading to a growing demand for effective treatments.

Underactive bladder, also known as detrusor underactivity, is a type of urinary incontinence that occurs when the muscles in the bladder wall are weakened, reducing the ability to contract and release urine effectively. The rising incidence of urinary incontinence has created a need for alternative treatment options, including drugs, devices, and surgery, driving the growth of the underactive bladder market. As a result, the increasing prevalence of urinary incontinence drives market growth.

Underactive Bladder

Report Segmentation

The market is primarily segmented based on treatment type, route of administration, end-user, distribution channel, and region.

By Treatment Type

By Route of Administration

By End User

By Distribution Channel

By Region

  • Pharmacotherapy
  • Surgical Methods
  • Urethral Assist Devices
  • Stem Cell and Gene Therapies
  • Oral
  • Parenteral
  • Others
  • Hospitals
  • Clinics
  • Academic and Research Institutes
  • Others
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

To Understand the Scope of this Report: Speak to Analyst

By Treatment Type Analysis

The urethral assist devices held the dominating revenue share in 2023.

The urethral assist device held the dominant revenue share in the underactive bladder market in 2023 due to its ability to effectively treat urinary retention and Benign Prostatic Hyperplasia (BPH). These devices are designed to support the urethra and help improve urine flow, reducing the symptoms of an underactive bladder. They are particularly useful for patients who have difficulty urinating or experience frequent urination, which are common symptoms of underactive bladders. Additionally, urethral assist devices are minimally invasive and can be easily inserted and removed, making them a preferred choice among patients and healthcare providers.

By End User Analysis

Hospitals segment dominated the global market in 2023.

The hospital segment dominated the global underactive bladder market in 2023 owing to several factors. Hospitals are the primary healthcare grounds where patients with urinary retention or other bladder disorders are typically diagnosed and treated. Hospitals have well-equipped facilities and trained healthcare professionals who can provide advanced treatments such as sacral neuromodulation therapy, which is a minimally invasive procedure that requires specialized equipment and expertise.

Along with this, many hospitals have dedicated urology departments that offer comprehensive care for bladder disorders, including surgical interventions and postoperative care. Hospitals often participate in clinical trials and research studies, which helps them stay up-to-date with the latest advancements in underactive bladder treatment technologies.

Underactive Bladder Seg

Regional Insights

North America region dominated the global market in 2023.

The North American region, which includes the United States and Canada, dominated the market in 2023 because of several factors, including a large aging population, a high prevalence of urinary incontinence, and increased awareness about the condition and available treatments. In addition, the presence of advanced healthcare infrastructure, well-established reimbursement policies, and a strong presence of key players in the region have contributed to the growth of the underactive bladder market in North America. Also, the increasing adoption of non-invasive and minimally invasive procedures, such as neuromodulation therapy and pelvic floor exercises, has fueled the demand for underactive bladder treatments in this region.

The European region is expected to experience significant growth in the market due to the increasing prevalence of urinary incontinence and overactive bladder symptoms among the senior population in countries such as Germany, France, the UK, and Italy, which is driving the demand for effective treatments, including underactive bladder therapies. Also, the rising awareness about the importance of early diagnosis and treatment of urinary disorders, associated with the growing availability of minimally invasive procedures, is propelling the adoption of underactive bladder treatments in the region.

Underactive Bladder Reg

Key Market Players & Competitive Insights

The treatment of underactive bladder (UAB) is a significant concern for many individuals, and several companies are actively involved in developing and providing solutions to address this issue. Pharmaceutical companies such as Pfizer, ASTELLAS PHARMA, and Dr Reddy’s Lab are engaged in the development of drugs that can help treat UAB symptoms, including urgency, frequency, and incontinence. In addition, healthcare providers and hospitals are offering various therapies and surgeries to treat UAB, including behavioral therapy, physical therapy, and surgery to repair or replace damaged nerves or muscles.

Some of the major players operating in the global market include:

  • Axonics, Inc.
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • Dr Reddy’s Laboratories Ltd
  • Novartis AG
  • Orion Corporation
  • Pfizer Inc.
  • Vesiflo

Recent Developments

  • In July 2022, Dr. Reddy’s Laboratories Ltd., a pharmaceutical company based in India that specializes in the development, manufacture, and sale of generic drugs, launched Fesoterodine Fumarate extended-release tablets, a therapeutic generic medication in the United States market after receiving approval from the U.S. Food and Drug Administration (USFDA).

Underactive Bladder Market Report Scope

Report Attributes


Market size value in 2024

USD 482.03 Million

Revenue Forecast in 2032

USD 728.06 Million


5.3% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD Million and CAGR from 2024 to 2032

Segments Covered

By Treatment Type, By Route of Administration, By End User, By Distribution Channel, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa


Report customization as per your requirements concerning countries, regions, and segmentation.


Delve into the intricacies of the underactive bladder in 2024 through the meticulously compiled market share, size, and revenue growth rate statistics by Polaris Market Research Industry Reports. Uncover a comprehensive analysis that not only projects market trends up to 2032 but also provides valuable insights into the historical landscape. Immerse yourself in the depth of this industry analysis by acquiring a complimentary PDF download of the sample report.


The Underactive Bladder Market report covering key segments are treatment type, route of administration, end user, distribution channel, and region.

The global underactive bladder market size is expected to reach USD 728.06 Million by 2032

The global underactive bladder market is expected to grow at a CAGR of 5.3% during the forecast period

North America regions is leading the global market.

Increasing prevalence of urinary incontinence are the key driving factors in Underactive Bladder Market.